 | • レポートコード：GIR-105X13143 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、オクスカルバゼピンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。オクスカルバゼピンの種類別市場規模（錠剤（150mg、300mg、600mg）、経口懸濁液）、用途別市場規模（小児用（2〜4歳、4〜16歳）、成人用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・オクスカルバゼピンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis (Trileptal)、Supernus Pharmaceuticals (Oxtellar XR)、Sun Pharm、Ranbaxy Pharmaceuticals、Jubilant Generics、Taro Pharmaceuticals、Mylan、Stada Group、Glenmark Pharmaceuticals、ANI Pharmaceuticals、Teva Pharmaceutical、Roxane Laboratories、Nobelpharma、Apotex、Nexgen pharma、Amneal Pharmaceuticals、Hikma Pharmaceuticals、Jamp Pharma、Neuraxpharm、Orion Corporation、Sihuan Pharm、Humanwell Healthcare、Huikang Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：錠剤（150mg、300mg、600mg）、経口懸濁液 ・用途別分析2016年-2026年：小児用（2〜4歳、4〜16歳）、成人用 ・オクスカルバゼピンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・オクスカルバゼピンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・オクスカルバゼピンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・オクスカルバゼピンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・オクスカルバゼピンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oxcarbazepine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oxcarbazepine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Oxcarbazepine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Oxcarbazepine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablets (150mg, 300mg, 600mg)
Oral Suspension
Market segment by Application can be divided into
Pediatric Use (Aged 2-4 years, 4-16 years)
Adult Use
The key market players for global Oxcarbazepine market are listed below:
Novartis (Trileptal)
Supernus Pharmaceuticals (Oxtellar XR)
Sun Pharm
Ranbaxy Pharmaceuticals
Jubilant Generics
Taro Pharmaceuticals
Mylan
Stada Group
Glenmark Pharmaceuticals
ANI Pharmaceuticals
Teva Pharmaceutical
Roxane Laboratories
Nobelpharma
Apotex
Nexgen pharma
Amneal Pharmaceuticals
Hikma Pharmaceuticals
Jamp Pharma
Neuraxpharm
Orion Corporation
Sihuan Pharm
Humanwell Healthcare
Huikang Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Oxcarbazepine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oxcarbazepine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Tablets (150mg, 300mg, 600mg)
1.2.3 Oral Suspension
1.3 Market Analysis by Application
1.3.1 Overview: Global Oxcarbazepine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pediatric Use (Aged 2-4 years, 4-16 years)
1.3.3 Adult Use
1.4 Global Oxcarbazepine Market Size & Forecast
1.4.1 Global Oxcarbazepine Sales in Value (2016-2026))
1.4.2 Global Oxcarbazepine Sales in Volume (2016-2026)
1.4.3 Global Oxcarbazepine Price by Type (2016-2026) & (USD/Unit)
1.5 Global Oxcarbazepine Production Capacity Analysis
1.5.1 Global Oxcarbazepine Total Production Capacity (2016-2026)
1.5.2 Global Oxcarbazepine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oxcarbazepine Market Drivers
1.6.2 Oxcarbazepine Market Restraints
1.6.3 Oxcarbazepine Trends Analysis
2 Manufacturers Profiles
2.1 Novartis (Trileptal)
2.1.1 Novartis (Trileptal) Details
2.1.2 Novartis (Trileptal) Major Business
2.1.3 Novartis (Trileptal) Oxcarbazepine Product and Services
2.1.4 Novartis (Trileptal) Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Supernus Pharmaceuticals (Oxtellar XR)
2.2.1 Supernus Pharmaceuticals (Oxtellar XR) Details
2.2.2 Supernus Pharmaceuticals (Oxtellar XR) Major Business
2.2.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product and Services
2.2.4 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Sun Pharm
2.3.1 Sun Pharm Details
2.3.2 Sun Pharm Major Business
2.3.3 Sun Pharm Oxcarbazepine Product and Services
2.3.4 Sun Pharm Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Ranbaxy Pharmaceuticals
2.4.1 Ranbaxy Pharmaceuticals Details
2.4.2 Ranbaxy Pharmaceuticals Major Business
2.4.3 Ranbaxy Pharmaceuticals Oxcarbazepine Product and Services
2.4.4 Ranbaxy Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Jubilant Generics
2.5.1 Jubilant Generics Details
2.5.2 Jubilant Generics Major Business
2.5.3 Jubilant Generics Oxcarbazepine Product and Services
2.5.4 Jubilant Generics Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Taro Pharmaceuticals
2.6.1 Taro Pharmaceuticals Details
2.6.2 Taro Pharmaceuticals Major Business
2.6.3 Taro Pharmaceuticals Oxcarbazepine Product and Services
2.6.4 Taro Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business
2.7.3 Mylan Oxcarbazepine Product and Services
2.7.4 Mylan Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Stada Group
2.8.1 Stada Group Details
2.8.2 Stada Group Major Business
2.8.3 Stada Group Oxcarbazepine Product and Services
2.8.4 Stada Group Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Glenmark Pharmaceuticals
2.9.1 Glenmark Pharmaceuticals Details
2.9.2 Glenmark Pharmaceuticals Major Business
2.9.3 Glenmark Pharmaceuticals Oxcarbazepine Product and Services
2.9.4 Glenmark Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 ANI Pharmaceuticals
2.10.1 ANI Pharmaceuticals Details
2.10.2 ANI Pharmaceuticals Major Business
2.10.3 ANI Pharmaceuticals Oxcarbazepine Product and Services
2.10.4 ANI Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Teva Pharmaceutical
2.11.1 Teva Pharmaceutical Details
2.11.2 Teva Pharmaceutical Major Business
2.11.3 Teva Pharmaceutical Oxcarbazepine Product and Services
2.11.4 Teva Pharmaceutical Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Roxane Laboratories
2.12.1 Roxane Laboratories Details
2.12.2 Roxane Laboratories Major Business
2.12.3 Roxane Laboratories Oxcarbazepine Product and Services
2.12.4 Roxane Laboratories Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Nobelpharma
2.13.1 Nobelpharma Details
2.13.2 Nobelpharma Major Business
2.13.3 Nobelpharma Oxcarbazepine Product and Services
2.13.4 Nobelpharma Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Apotex
2.14.1 Apotex Details
2.14.2 Apotex Major Business
2.14.3 Apotex Oxcarbazepine Product and Services
2.14.4 Apotex Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Nexgen pharma
2.15.1 Nexgen pharma Details
2.15.2 Nexgen pharma Major Business
2.15.3 Nexgen pharma Oxcarbazepine Product and Services
2.15.4 Nexgen pharma Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Amneal Pharmaceuticals
2.16.1 Amneal Pharmaceuticals Details
2.16.2 Amneal Pharmaceuticals Major Business
2.16.3 Amneal Pharmaceuticals Oxcarbazepine Product and Services
2.16.4 Amneal Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Hikma Pharmaceuticals
2.17.1 Hikma Pharmaceuticals Details
2.17.2 Hikma Pharmaceuticals Major Business
2.17.3 Hikma Pharmaceuticals Oxcarbazepine Product and Services
2.17.4 Hikma Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Jamp Pharma
2.18.1 Jamp Pharma Details
2.18.2 Jamp Pharma Major Business
2.18.3 Jamp Pharma Oxcarbazepine Product and Services
2.18.4 Jamp Pharma Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.19 Neuraxpharm
2.19.1 Neuraxpharm Details
2.19.2 Neuraxpharm Major Business
2.19.3 Neuraxpharm Oxcarbazepine Product and Services
2.19.4 Neuraxpharm Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.20 Orion Corporation
2.20.1 Orion Corporation Details
2.20.2 Orion Corporation Major Business
2.20.3 Orion Corporation Oxcarbazepine Product and Services
2.20.4 Orion Corporation Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.21 Sihuan Pharm
2.21.1 Sihuan Pharm Details
2.21.2 Sihuan Pharm Major Business
2.21.3 Sihuan Pharm Oxcarbazepine Product and Services
2.21.4 Sihuan Pharm Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.22 Humanwell Healthcare
2.22.1 Humanwell Healthcare Details
2.22.2 Humanwell Healthcare Major Business
2.22.3 Humanwell Healthcare Oxcarbazepine Product and Services
2.22.4 Humanwell Healthcare Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.23 Huikang Pharmaceutical
2.23.1 Huikang Pharmaceutical Details
2.23.2 Huikang Pharmaceutical Major Business
2.23.3 Huikang Pharmaceutical Oxcarbazepine Product and Services
2.23.4 Huikang Pharmaceutical Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Oxcarbazepine Sales by Manufacturer
3.1 Global Oxcarbazepine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Oxcarbazepine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Oxcarbazepine
3.4 Market Concentration Rate
3.4.1 Top 3 Oxcarbazepine Manufacturer Market Share
3.4.2 Top 6 Oxcarbazepine Manufacturer Market Share
3.5 Global Oxcarbazepine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Oxcarbazepine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oxcarbazepine Market Size by Region
4.1.1 Global Oxcarbazepine Sales in Volume by Region (2016-2026)
4.1.2 Global Oxcarbazepine Revenue by Region (2016-2026)
4.2 North America Oxcarbazepine Revenue (2016-2026)
4.3 Europe Oxcarbazepine Revenue (2016-2026)
4.4 Asia-Pacific Oxcarbazepine Revenue (2016-2026)
4.5 South America Oxcarbazepine Revenue (2016-2026)
4.6 Middle East and Africa Oxcarbazepine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Oxcarbazepine Sales in Volume by Type (2016-2026)
5.2 Global Oxcarbazepine Revenue by Type (2016-2026)
5.3 Global Oxcarbazepine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Oxcarbazepine Sales in Volume by Application (2016-2026)
6.2 Global Oxcarbazepine Revenue by Application (2016-2026)
6.3 Global Oxcarbazepine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Oxcarbazepine Sales by Type (2016-2026)
7.2 North America Oxcarbazepine Sales by Application (2016-2026)
7.3 North America Oxcarbazepine Market Size by Country
7.3.1 North America Oxcarbazepine Sales in Volume by Country (2016-2026)
7.3.2 North America Oxcarbazepine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Oxcarbazepine Sales by Type (2016-2026)
8.2 Europe Oxcarbazepine Sales by Application (2016-2026)
8.3 Europe Oxcarbazepine Market Size by Country
8.3.1 Europe Oxcarbazepine Sales in Volume by Country (2016-2026)
8.3.2 Europe Oxcarbazepine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Oxcarbazepine Sales by Type (2016-2026)
9.2 Asia-Pacific Oxcarbazepine Sales by Application (2016-2026)
9.3 Asia-Pacific Oxcarbazepine Market Size by Region
9.3.1 Asia-Pacific Oxcarbazepine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Oxcarbazepine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Oxcarbazepine Sales by Type (2016-2026)
10.2 South America Oxcarbazepine Sales by Application (2016-2026)
10.3 South America Oxcarbazepine Market Size by Country
10.3.1 South America Oxcarbazepine Sales in Volume by Country (2016-2026)
10.3.2 South America Oxcarbazepine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oxcarbazepine Sales by Type (2016-2026)
11.2 Middle East & Africa Oxcarbazepine Sales by Application (2016-2026)
11.3 Middle East & Africa Oxcarbazepine Market Size by Country
11.3.1 Middle East & Africa Oxcarbazepine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Oxcarbazepine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Oxcarbazepine Typical Distributors
12.3 Oxcarbazepine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Oxcarbazepine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Oxcarbazepine Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis (Trileptal) Basic Information, Manufacturing Base and Competitors
Table 4. Novartis (Trileptal) Major Business
Table 5. Novartis (Trileptal) Oxcarbazepine Product and Services
Table 6. Novartis (Trileptal) Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Supernus Pharmaceuticals (Oxtellar XR) Basic Information, Manufacturing Base and Competitors
Table 8. Supernus Pharmaceuticals (Oxtellar XR) Major Business
Table 9. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product and Services
Table 10. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sun Pharm Basic Information, Manufacturing Base and Competitors
Table 12. Sun Pharm Major Business
Table 13. Sun Pharm Oxcarbazepine Product and Services
Table 14. Sun Pharm Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Ranbaxy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Ranbaxy Pharmaceuticals Major Business
Table 17. Ranbaxy Pharmaceuticals Oxcarbazepine Product and Services
Table 18. Ranbaxy Pharmaceuticals Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Jubilant Generics Basic Information, Manufacturing Base and Competitors
Table 20. Jubilant Generics Major Business
Table 21. Jubilant Generics Oxcarbazepine Product and Services
Table 22. Jubilant Generics Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Taro Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Taro Pharmaceuticals Major Business
Table 25. Taro Pharmaceuticals Oxcarbazepine Product and Services
Table 26. Taro Pharmaceuticals Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Mylan Basic Information, Manufacturing Base and Competitors
Table 28. Mylan Major Business
Table 29. Mylan Oxcarbazepine Product and Services
Table 30. Mylan Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Stada Group Basic Information, Manufacturing Base and Competitors
Table 32. Stada Group Major Business
Table 33. Stada Group Oxcarbazepine Product and Services
Table 34. Stada Group Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Glenmark Pharmaceuticals Major Business
Table 37. Glenmark Pharmaceuticals Oxcarbazepine Product and Services
Table 38. Glenmark Pharmaceuticals Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. ANI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. ANI Pharmaceuticals Major Business
Table 41. ANI Pharmaceuticals Oxcarbazepine Product and Services
Table 42. ANI Pharmaceuticals Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Teva Pharmaceutical Major Business
Table 45. Teva Pharmaceutical Oxcarbazepine Product and Services
Table 46. Teva Pharmaceutical Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Roxane Laboratories Basic Information, Manufacturing Base and Competitors
Table 48. Roxane Laboratories Major Business
Table 49. Roxane Laboratories Oxcarbazepine Product and Services
Table 50. Roxane Laboratories Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Nobelpharma Basic Information, Manufacturing Base and Competitors
Table 52. Nobelpharma Major Business
Table 53. Nobelpharma Oxcarbazepine Product and Services
Table 54. Nobelpharma Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Apotex Basic Information, Manufacturing Base and Competitors
Table 56. Apotex Major Business
Table 57. Apotex Oxcarbazepine Product and Services
Table 58. Apotex Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Nexgen pharma Basic Information, Manufacturing Base and Competitors
Table 60. Nexgen pharma Major Business
Table 61. Nexgen pharma Oxcarbazepine Product and Services
Table 62. Nexgen pharma Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Amneal Pharmaceuticals Major Business
Table 65. Amneal Pharmaceuticals Oxcarbazepine Product and Services
Table 66. Amneal Pharmaceuticals Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Hikma Pharmaceuticals Major Business
Table 69. Hikma Pharmaceuticals Oxcarbazepine Product and Services
Table 70. Hikma Pharmaceuticals Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Jamp Pharma Basic Information, Manufacturing Base and Competitors
Table 72. Jamp Pharma Major Business
Table 73. Jamp Pharma Oxcarbazepine Product and Services
Table 74. Jamp Pharma Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Neuraxpharm Basic Information, Manufacturing Base and Competitors
Table 76. Neuraxpharm Major Business
Table 77. Neuraxpharm Oxcarbazepine Product and Services
Table 78. Neuraxpharm Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Orion Corporation Basic Information, Manufacturing Base and Competitors
Table 80. Orion Corporation Major Business
Table 81. Orion Corporation Oxcarbazepine Product and Services
Table 82. Orion Corporation Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Sihuan Pharm Basic Information, Manufacturing Base and Competitors
Table 84. Sihuan Pharm Major Business
Table 85. Sihuan Pharm Oxcarbazepine Product and Services
Table 86. Sihuan Pharm Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Humanwell Healthcare Basic Information, Manufacturing Base and Competitors
Table 88. Humanwell Healthcare Major Business
Table 89. Humanwell Healthcare Oxcarbazepine Product and Services
Table 90. Humanwell Healthcare Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Huikang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Huikang Pharmaceutical Major Business
Table 93. Huikang Pharmaceutical Oxcarbazepine Product and Services
Table 94. Huikang Pharmaceutical Oxcarbazepine Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Global Oxcarbazepine Sales by Manufacturer (2019-2021e) & (M Unit)
Table 96. Global Oxcarbazepine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 97. Market Position of Manufacturers in Oxcarbazepine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 98. Global Oxcarbazepine Production Capacity by Company, (M Unit): 2020 VS 2021
Table 99. Head Office and Oxcarbazepine Production Site of Key Manufacturer
Table 100. Global Oxcarbazepine Sales by Region (2016-2021e) & (M Unit)
Table 101. Global Oxcarbazepine Sales by Region (2021-2026) & (M Unit)
Table 102. Global Oxcarbazepine Revenue by Region (2016-2021e) & (USD Million)
Table 103. Global Oxcarbazepine Revenue by Region (2021-2026) & (USD Million)
Table 104. Global Oxcarbazepine Sales by Type (2016-2021e) & (M Unit)
Table 105. Global Oxcarbazepine Sales by Type (2021-2026) & (M Unit)
Table 106. Global Oxcarbazepine Revenue by Type (2016-2021e) & (USD Million)
Table 107. Global Oxcarbazepine Revenue by Type (2021-2026) & (USD Million)
Table 108. Global Oxcarbazepine Price by Type (2016-2021e) & (USD/Unit)
Table 109. Global Oxcarbazepine Price by Type (2021-2026) & (USD/Unit)
Table 110. Global Oxcarbazepine Sales by Application (2016-2021e) & (M Unit)
Table 111. Global Oxcarbazepine Sales by Application (2021-2026) & (M Unit)
Table 112. Global Oxcarbazepine Revenue by Application (2016-2021e) & (USD Million)
Table 113. Global Oxcarbazepine Revenue by Application (2021-2026) & (USD Million)
Table 114. Global Oxcarbazepine Price by Application (2016-2021e) & (USD/Unit)
Table 115. Global Oxcarbazepine Price by Application (2021-2026) & (USD/Unit)
Table 116. North America Oxcarbazepine Sales by Country (2016-2021e) & (M Unit)
Table 117. North America Oxcarbazepine Sales by Country (2021-2026) & (M Unit)
Table 118. North America Oxcarbazepine Revenue by Country (2016-2021e) & (USD Million)
Table 119. North America Oxcarbazepine Revenue by Country (2021-2026) & (USD Million)
Table 120. North America Oxcarbazepine Sales by Type (2016-2021e) & (M Unit)
Table 121. North America Oxcarbazepine Sales by Type (2021-2026) & (M Unit)
Table 122. North America Oxcarbazepine Sales by Application (2016-2021e) & (M Unit)
Table 123. North America Oxcarbazepine Sales by Application (2021-2026) & (M Unit)
Table 124. Europe Oxcarbazepine Sales by Country (2016-2021e) & (M Unit)
Table 125. Europe Oxcarbazepine Sales by Country (2021-2026) & (M Unit)
Table 126. Europe Oxcarbazepine Revenue by Country (2016-2021e) & (USD Million)
Table 127. Europe Oxcarbazepine Revenue by Country (2021-2026) & (USD Million)
Table 128. Europe Oxcarbazepine Sales by Type (2016-2021e) & (M Unit)
Table 129. Europe Oxcarbazepine Sales by Type (2021-2026) & (M Unit)
Table 130. Europe Oxcarbazepine Sales by Application (2016-2021e) & (M Unit)
Table 131. Europe Oxcarbazepine Sales by Application (2021-2026) & (M Unit)
Table 132. Asia-Pacific Oxcarbazepine Sales by Region (2016-2021e) & (M Unit)
Table 133. Asia-Pacific Oxcarbazepine Sales by Region (2021-2026) & (M Unit)
Table 134. Asia-Pacific Oxcarbazepine Revenue by Region (2016-2021e) & (USD Million)
Table 135. Asia-Pacific Oxcarbazepine Revenue by Region (2021-2026) & (USD Million)
Table 136. Asia-Pacific Oxcarbazepine Sales by Type (2016-2021e) & (M Unit)
Table 137. Asia-Pacific Oxcarbazepine Sales by Type (2021-2026) & (M Unit)
Table 138. Asia-Pacific Oxcarbazepine Sales by Application (2016-2021e) & (M Unit)
Table 139. Asia-Pacific Oxcarbazepine Sales by Application (2021-2026) & (M Unit)
Table 140. South America Oxcarbazepine Sales by Country (2016-2021e) & (M Unit)
Table 141. South America Oxcarbazepine Sales by Country (2021-2026) & (M Unit)
Table 142. South America Oxcarbazepine Revenue by Country (2016-2021e) & (USD Million)
Table 143. South America Oxcarbazepine Revenue by Country (2021-2026) & (USD Million)
Table 144. South America Oxcarbazepine Sales by Type (2016-2021e) & (M Unit)
Table 145. South America Oxcarbazepine Sales by Type (2021-2026) & (M Unit)
Table 146. South America Oxcarbazepine Sales by Application (2016-2021e) & (M Unit)
Table 147. South America Oxcarbazepine Sales by Application (2021-2026) & (M Unit)
Table 148. Middle East & Africa Oxcarbazepine Sales by Country (2016-2021e) & (M Unit)
Table 149. Middle East & Africa Oxcarbazepine Sales by Country (2021-2026) & (M Unit)
Table 150. Middle East & Africa Oxcarbazepine Revenue by Country (2016-2021e) & (USD Million)
Table 151. Middle East & Africa Oxcarbazepine Revenue by Country (2021-2026) & (USD Million)
Table 152. Middle East & Africa Oxcarbazepine Sales by Type (2016-2021e) & (M Unit)
Table 153. Middle East & Africa Oxcarbazepine Sales by Type (2021-2026) & (M Unit)
Table 154. Middle East & Africa Oxcarbazepine Sales by Application (2016-2021e) & (M Unit)
Table 155. Middle East & Africa Oxcarbazepine Sales by Application (2021-2026) & (M Unit)
Table 156. Direct Channel Pros & Cons
Table 157. Indirect Channel Pros & Cons
Table 158. Oxcarbazepine Typical Distributors
Table 159. Oxcarbazepine Typical Customers
List of Figures
Figure 1. Oxcarbazepine Picture
Figure 2. Global Oxcarbazepine Sales Market Share by Type in 2020
Figure 3. Tablets (150mg, 300mg, 600mg)
Figure 4. Oral Suspension
Figure 5. Global Oxcarbazepine Sales Market Share by Application in 2020
Figure 6. Pediatric Use (Aged 2-4 years, 4-16 years)
Figure 7. Adult Use
Figure 8. Global Oxcarbazepine Market Size, (USD Million) & (M Unit): 2020 VS 2021 VS 2026
Figure 9. Global Oxcarbazepine Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Oxcarbazepine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Oxcarbazepine Sales (2016-2026) & (M Unit)
Figure 30. Global Oxcarbazepine Production Capacity (2016-2026) & (M Unit)
Figure 31. Global Oxcarbazepine Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Oxcarbazepine Market Drivers
Figure 33. Oxcarbazepine Market Restraints
Figure 34. Oxcarbazepine Market Trends
Figure 35. Global Oxcarbazepine Sales Market Share by Manufacturer in 2020
Figure 36. Global Oxcarbazepine Revenue Market Share by Manufacturer in 2020
Figure 37. Oxcarbazepine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Oxcarbazepine Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Oxcarbazepine Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Oxcarbazepine Sales Market Share by Region (2016-2026)
Figure 41. Global Oxcarbazepine Revenue Market Share by Region (2016-2026)
Figure 42. North America Oxcarbazepine Revenue (2016-2026) & (USD Million)
Figure 43. Europe Oxcarbazepine Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Oxcarbazepine Revenue (2016-2026) & (USD Million)
Figure 45. South America Oxcarbazepine Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Oxcarbazepine Revenue (2016-2026) & (USD Million)
Figure 47. Global Oxcarbazepine Sales Market Share by Type (2016-2026)
Figure 48. Global Oxcarbazepine Revenue Market Share by Type (2016-2026)
Figure 49. Global Oxcarbazepine Price by Type (2016-2026) & (USD/Unit)
Figure 50. Global Oxcarbazepine Sales Market Share by Application (2016-2026)
Figure 51. Global Oxcarbazepine Revenue Market Share by Application (2016-2026)
Figure 52. Global Oxcarbazepine Price by Application (2016-2026) & (USD/Unit)
Figure 53. North America Oxcarbazepine Sales Market Share by Country (2016-2026)
Figure 54. North America Oxcarbazepine Revenue Market Share by Country (2016-2026)
Figure 55. North America Oxcarbazepine Sales Market Share by Type (2016-2026)
Figure 56. North America Oxcarbazepine Sales Market Share by Application (2016-2026)
Figure 57. Europe Oxcarbazepine Sales Market Share by Country (2016-2026)
Figure 58. Europe Oxcarbazepine Revenue Market Share by Country (2016-2026)
Figure 59. Europe Oxcarbazepine Sales Market Share by Type (2016-2026)
Figure 60. Europe Oxcarbazepine Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Oxcarbazepine Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Oxcarbazepine Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Oxcarbazepine Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Oxcarbazepine Sales Market Share by Application (2016-2026)
Figure 65. South America Oxcarbazepine Sales Market Share by Country (2016-2026)
Figure 66. South America Oxcarbazepine Revenue Market Share by Country (2016-2026)
Figure 67. South America Oxcarbazepine Sales Market Share by Type (2016-2026)
Figure 68. South America Oxcarbazepine Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Oxcarbazepine Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Oxcarbazepine Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Oxcarbazepine Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Oxcarbazepine Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界のオクスカルバゼピン錠市場 2021：企業別、地域別、種類・用途別 The Oxcarbazepine Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…- オクスカルバゼピン薬の世界市場2018-2025 Oxcarbazepine is an anticonvulsant medication primarily used in the treatment of epilepsy. It may also be used as add-on therapy for bipolar disorder in people that have failed or are unable to tolerate other treatments.In 2018, the global Oxcarbazepine Drug market size was xx million US$ and is for…
- 世界のオクスカルバゼピンAPI市場 2021：企業別、地域別、種類・用途別 The Oxcarbazepine API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
- 大人用・小児用血液濃縮装置の世界市場2018-2025 The Adult and Pediatric Hemoconcentrators market was valued at xx Million US$ in 2017 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market…
- ドキシサイクリンヒクラート経口の世界市場2018-2025 This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria.In 2018, the global Doxycycline Hyclate Oral m…